Male circumcision to reduce the risk of HIV and sexually transmitted infections among men who have sex with men

Current Opinion in Infectious Diseases
David J TempletonAndrew Grulich

Abstract

The success of male circumcision in reducing HIV acquisition among African heterosexuals has led to renewed interest in this biological intervention for HIV/sexually transmissible infection (STI) prevention in men who have sex with men (MSM). This review summarizes the available data on the association of circumcision and HIV/STI among MSM populations. Results of observational studies indicate that circumcision has limited impact on HIV/STI acquisition among MSM populations overall. Longitudinal data suggest that circumcision may reduce the risk of incident syphilis, but there is little evidence of a protective effect for other STIs. The subgroup of MSM who predominantly practise the insertive role in anal intercourse may be at lower risk of HIV, although the relative inefficiency of HIV acquisition for insertive compared with receptive partners has resulted in imprecise estimates of effect. The evidence that circumcision reduces HIV and other STIs among MSM is weak and inconsistent. However, recent studies have found that circumcised MSM who predominantly take the insertive role in anal intercourse may be at a lower risk of HIV infection. Although MSM may be willing to undergo adult circumcision, should it be proven to reduce ...Continue Reading

References

Dec 1, 1993·The Journal of Infectious Diseases·J K Kreiss, S G Hopkins
Feb 28, 2002·American Journal of Public Health·Mitchell H KatzWilliam McFarland
Apr 27, 2005·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Susan P BuchbinderBeryl A Koblin
Jun 21, 2005·Infectious Disease Clinics of North America·Kevin A Fenton, John Imrie
Jul 19, 2006·AIDS·Scott G McCoombe, Roger V Short
Aug 24, 2006·International Journal of STD & AIDS·Juliet RichtersChristopher E Rissel
Jan 2, 2007·Current Opinion in Infectious Diseases·Helen A Weiss
Jan 20, 2007·BMJ : British Medical Journal·Patrick French
Feb 16, 2007·AIDS·Neil C SheppardQuentin J Sattentau
Apr 28, 2007·American Journal of Public Health·Miguel Muñoz-Laboy, Brian Dodge
Aug 28, 2007·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Fengyi JinAndrew E Grulich
Oct 18, 2007·Journal of the American Academy of Dermatology·Mahnaz Fatahzadeh, Robert A Schwartz
Nov 29, 2007·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Gregorio A MillettGary Marks
Dec 8, 2007·BMJ : British Medical Journal·Padraig Malone, Henrik Steinbrecher
Feb 20, 2008·Sexually Transmitted Infections·Abigail MacdonaldHarold W Jaffe
Feb 21, 2008·The Journal of Infectious Diseases·B Y HernandezM T Goodman
Mar 5, 2008·AIDS·Helen A WeissCatherine A Hankins
Apr 4, 2008·Sexually Transmitted Infections·D J TempletonA E Grulich
May 9, 2008·Current Infectious Disease Reports·Ronald H GrayDavid Serwadda
May 30, 2008·Archives of Sexual Behavior·Darrell P WheelerChristopher Murrill
Nov 13, 2008·Journal of LGBT Health Research·Carol A ReisenFernanda T Bianchi
Mar 27, 2009·The New England Journal of Medicine·Aaron A R TobianRonald H Gray
Sep 16, 2009·AIDS·David J TempletonAndrew E Grulich

❮ Previous
Next ❯

Citations

Nov 26, 2010·The New England Journal of Medicine·Robert M GrantUNKNOWN iPrEx Study Team
Dec 15, 2012·SAHARA J : Journal of Social Aspects of HIV/AIDS Research Alliance·K RebeJ A McIntyre
Aug 14, 2013·Global Public Health·Kenneth Rochel de CamargoAlain Giami
Sep 22, 2011·Sexually Transmitted Diseases·Alicia C ThorntonJonathan Elford
Nov 26, 2010·AIDS·Jorge SánchezConnie Celum
Jul 3, 2010·Sexually Transmitted Infections·Lisa M McDaidGraham J Hart
Jul 31, 2014·PloS One·Steven M GoodreauSusan P Buchbinder
Jul 14, 2010·British Journal of Nursing : BJN·Natasha Larke
Aug 1, 2014·Artificial Cells, Nanomedicine, and Biotechnology·Wenya YuJinkou Zhao
May 29, 2012·The Journal of the Association of Nurses in AIDS Care : JANAC·J Craig PhillipsCarol A Pat Patsdaughter
Oct 7, 2014·The Journal of Sexual Medicine·Jennifer A BossioStephen Steele
Jun 25, 2015·AIDS Research and Human Retroviruses·Nittaya PhanuphakJean Louis Excler
May 9, 2015·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·S StromdahlA Thorson
Jan 8, 2011·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Olalekan A UthmanOlatunde Aremu
Jul 5, 2013·International Journal of Public Health·Abdulsalam Alkaiyat, Mitchell G Weiss
Aug 21, 2014·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·I Stratov, S J Kent
Feb 23, 2017·World Journal of Clinical Pediatrics·Brian J MorrisJohn B Ziegler
Jun 15, 2010·Current Opinion in HIV and AIDS·David J Templeton
Oct 16, 2014·The Open AIDS Journal·Parana H M JayathungeStuart Turville
May 19, 2011·World Journal of Urology·John N Krieger
May 4, 2011·Current Opinion in HIV and AIDS·Sheldon R Morris, Susan J Little
Jun 17, 2011·The Cochrane Database of Systematic Reviews·Charles Shey WiysongeYing-Ru Lo
Sep 29, 2015·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Han-Zhu QianSten H Vermund
Nov 2, 2013·JAAPA : Official Journal of the American Academy of Physician Assistants·Jonathan Baker

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.